T W Meade

Summary

Affiliation: Queen Mary
Country: UK

Publications

  1. pmc Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN4119421]
    Thomas W Meade
    MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, London, UK
    Curr Control Trials Cardiovasc Med 2:195-204. 2001
  2. pmc Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial
    T W Meade
    MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, London, EC1M 6BQ
    BMJ 321:13-7. 2000
  3. doi request reprint Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case-control study
    A R Rudnicka
    Division of Community Health Sciences, St George s, University of London, and Ophthalmology Department, Barts and The London NHS Trust, St Bartholomew s Hospital, Cranmer Terrace, London, UK
    Eye (Lond) 24:1199-206. 2010
  4. doi request reprint Assessing the contribution of fibrinogen in predicting risk of death in men with peripheral arterial disease
    J W Bartlett
    London School of Hygiene and Tropical Medicine, London, UK
    J Thromb Haemost 7:270-6. 2009
  5. ncbi request reprint Haemostatic and lipid determinants of prothrombin fragment F1.2 and D-dimer in plasma
    P K MacCallum
    MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, St Bartholomew s and The Royal London School of Medicine, UK
    Thromb Haemost 83:421-6. 2000
  6. ncbi request reprint Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels
    J A Wedzicha
    Department of Academic Respiratory Medicine, St Bartholomew s and Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, London, UK
    Thromb Haemost 84:210-5. 2000
  7. ncbi request reprint Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease
    T Seemungal
    Academic Department of Respiratory Medicine and Virology, St. Bartholomew's and Royal London School of Medicine and Dentistry, London, UK
    Am J Respir Crit Care Med 164:1618-23. 2001
  8. ncbi request reprint Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I)
    B L De Stavola
    Medical Statistics Unit, London School of Hygiene and Tropical Medicine, London, UK
    J Thromb Haemost 5:461-71. 2007
  9. ncbi request reprint Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial
    A R Rudnicka
    Division of Community Health Sciences, St George s, University of London, London, UK
    J Thromb Haemost 4:2405-10. 2006
  10. pmc Thrombosis prevention trial: follow-up study of practical implications
    N Fasey
    MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, London
    Br J Gen Pract 52:208-9. 2002

Collaborators

Detail Information

Publications13

  1. pmc Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN4119421]
    Thomas W Meade
    MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, London, UK
    Curr Control Trials Cardiovasc Med 2:195-204. 2001
    ..Although bezafibrate lowers fibrinogen, it has no effect on CRP; this suggests that the reduction in fibrinogen is due to an effect on its metabolism rather than suppression of an inflammatory response...
  2. pmc Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial
    T W Meade
    MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, London, EC1M 6BQ
    BMJ 321:13-7. 2000
    ..To determine which groups of patients may derive particular benefit or experience harm from the use of low dose aspirin for the primary prevention of coronary heart disease...
  3. doi request reprint Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case-control study
    A R Rudnicka
    Division of Community Health Sciences, St George s, University of London, and Ophthalmology Department, Barts and The London NHS Trust, St Bartholomew s Hospital, Cranmer Terrace, London, UK
    Eye (Lond) 24:1199-206. 2010
    ..The aim of this study was to examine the relation of late-stage age-related macular degeneration (AMD) with markers of systemic atherothrombosis...
  4. doi request reprint Assessing the contribution of fibrinogen in predicting risk of death in men with peripheral arterial disease
    J W Bartlett
    London School of Hygiene and Tropical Medicine, London, UK
    J Thromb Haemost 7:270-6. 2009
    ..Although fibrinogen is known to be an independent population-level risk factor for cardiovascular disease in healthy individuals, less is known about its value for individual-level risk prediction...
  5. ncbi request reprint Haemostatic and lipid determinants of prothrombin fragment F1.2 and D-dimer in plasma
    P K MacCallum
    MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, St Bartholomew s and The Royal London School of Medicine, UK
    Thromb Haemost 83:421-6. 2000
    ..e. F1.2). Determinants of D-dimer differ according to age and interpretation of the biological significance of D-dimer levels in epidemiological studies may therefore not be straightforward...
  6. ncbi request reprint Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels
    J A Wedzicha
    Department of Academic Respiratory Medicine, St Bartholomew s and Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, London, UK
    Thromb Haemost 84:210-5. 2000
    ....
  7. ncbi request reprint Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease
    T Seemungal
    Academic Department of Respiratory Medicine and Virology, St. Bartholomew's and Royal London School of Medicine and Dentistry, London, UK
    Am J Respir Crit Care Med 164:1618-23. 2001
    ..Prevention and early treatment of viral infections may lead to a decreased exacerbation frequency and morbidity associated with COPD...
  8. ncbi request reprint Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I)
    B L De Stavola
    Medical Statistics Unit, London School of Hygiene and Tropical Medicine, London, UK
    J Thromb Haemost 5:461-71. 2007
    ..The long-term associations of established risk factors for coronary heart disease (CHD), for example cholesterol, are well known, but not for the less familiar hemostatic variables...
  9. ncbi request reprint Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial
    A R Rudnicka
    Division of Community Health Sciences, St George s, University of London, London, UK
    J Thromb Haemost 4:2405-10. 2006
    ..As with 'conventional' risk factors such as cholesterol and smoking, there is a need for large, long-term prospective studies on hemostatic factors...
  10. pmc Thrombosis prevention trial: follow-up study of practical implications
    N Fasey
    MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, London
    Br J Gen Pract 52:208-9. 2002
    ....
  11. ncbi request reprint Cardiovascular disease--linking pathology and epidemiology
    T W Meade
    MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, Charterhouse Square, London EC1M 6BQ, UK
    Int J Epidemiol 30:1179-83. 2001
    ..Much of our current knowledge about the origins, management and prevention of CHD stems from Morris's early studies linking pathology and epidemiology...
  12. ncbi request reprint Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial
    Y Jamshidi
    Centre for Cardiovascular Genetics, Department of Medicine, Royal Free and University College London Medical School, The Rayne Institute, London, UK
    Atherosclerosis 163:183-92. 2002
    ....
  13. ncbi request reprint Fibrinogen measurement to assess the risk of arterial thrombosis in individual patients: yes
    T W Meade
    London School of Hygiene and Tropical Medicine, London, UK
    J Thromb Haemost 3:632-4. 2005